Related references
Note: Only part of the references are listed.Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007
Graca M. Dores et al.
BLOOD (2012)
Pharmacokinetics and Safety of Marqibo (Vincristine Sulfate Liposomes Injection) in Cancer Patients With Impaired Liver Function
Agop Y. Bedikian et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia
Anjali S. Advani et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Phase 1 Multicenter Study of Vincristine Sulfate Liposomes Injection and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia
Deborah A. Thomas et al.
CANCER (2009)
Outcome of Adults With Acute Lymphocytic Leukemia After Second Salvage Therapy
Susan O'Brien et al.
CANCER (2008)
Progress in the treatment of adults with acute lymphoblastic leukemia
Sarah Larson et al.
CURRENT OPINION IN HEMATOLOGY (2008)
FDA drug approval summary: Nelarabine (Arranon (R)) for the treatment of T-cell lymphoblastic leukemia/lymphoma
Martin H. Cohen et al.
ONCOLOGIST (2008)
Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial
E. Tavernier et al.
LEUKEMIA (2007)
End points to establish the efficacy of new agents in the treatment of acute leukemia
Frederick R. Appelbaum et al.
BLOOD (2007)
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study
Adele K. Fielding et al.
BLOOD (2007)
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia
H Kantarjian et al.
CANCER (2004)
In vivo administration of liposomal vincristine sensitizes drug-resistant human solid tumors
C Leonetti et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
BD Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia
H Kantarjian et al.
BLOOD (2003)
Share Paper
